# Severe Initial Presentation of Systemic Lupus Erythematosus Mimicking Hemophagocytic Lymphohistiocytosis Secondary to Epstein-Barr Virus (EBV): A Case Report

**Authors:** James Di Palma-Grisi, Alexander Vallone, Sophia Zhang, Egor Volcotrub, Danit Arad

PMC · DOI: 10.7759/cureus.100085 · Cureus · 2025-12-25

## TL;DR

A woman with severe lupus symptoms initially thought to have a rare immune disorder was correctly diagnosed with systemic lupus erythematosus after her condition improved with treatment.

## Contribution

This case highlights the diagnostic challenge of SLE mimicking EBV-related HLH and emphasizes the importance of rheumatological evaluation.

## Key findings

- The patient's symptoms initially mimicked hemophagocytic lymphohistiocytosis due to EBV.
- Treatment with dexamethasone improved symptoms, but a lupus diagnosis was later confirmed.
- Lupus nephritis was confirmed via kidney biopsy, supporting the final SLE diagnosis.

## Abstract

A Hispanic woman in her fifth decade of life presented to the Emergency Department with severe abdominal pain, dry heaving, fevers, and weight loss for two weeks. She underwent a CT of the abdomen and pelvis, notable for appendiceal thickening, and was diagnosed with subacute appendicitis with regional lymphadenopathy, thought to be reactive. Her fever persisted on empiric antibiotics, and she underwent a total-body CT that showed diffuse lymphadenopathy. She developed pancytopenia, underwent a bone marrow biopsy, and was started on high-dose dexamethasone with concern for hemophagocytic lymphohistiocytosis (HLH). Her symptoms improved on dexamethasone but remained persistent throughout her tapering, and she underwent rheumatological evaluation given her family history of systemic lupus erythematosus (SLE) in her adult daughter. She was found to have positive anti-double-stranded DNA (anti-dsDNA) antibodies, was started on hydroxychloroquine, improved, and was discharged from the hospital with outpatient rheumatology follow-up. Later, her kidney biopsy was positive for lupus nephritis, confirming the diagnosis.

## Linked entities

- **Chemicals:** hydroxychloroquine (PubChem CID 3652), dexamethasone (PubChem CID 5743)
- **Diseases:** systemic lupus erythematosus (MONDO:0007915), hemophagocytic lymphohistiocytosis (MONDO:0015540), lupus nephritis (MONDO:0005556)

## Full-text entities

- **Diseases:** lymphadenopathy (MESH:D008206), fever (MESH:D005334), abdominal pain (MESH:D015746), pancytopenia (MESH:D010198), weight loss (MESH:D015431), lupus nephritis (MESH:D008181), SLE (MESH:D008180), HLH (MESH:D051359), appendicitis (MESH:D001064)
- **Chemicals:** dexamethasone (MESH:D003907), hydroxychloroquine (MESH:D006886)
- **Species:** Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831648/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12831648/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12831648/full.md

---
Source: https://tomesphere.com/paper/PMC12831648